Search Results 201-210 of 18413 for prednisone

1. Body Builder Regains Energy After Surgery for Myasthenia Gravis - Mayo Clinic News Network

   Instead, he began taking prednisone to help manage his symptoms. But the medication had side effects. “My second youngest daughter was born when I was ...

2. A Randomized Multicenter Study for Isolated Skin Vasculitis - Mayo Clinic

   For the patients on prednisone at the time of enrollment, prednisone should be stopped within a maximum of 6 weeks after enrollment and initiation of the ...

3. A Study to Assess the Efficacy and Safety of Risankizumab in Subjects With Moderately to Severely Active Crohn's Disease Who Failed Prior Biologic Treatment - Mayo Clinic

   Prednisone or equivalent > 20 mg/day;; Or has not been on the current course for ≥ 14 days prior to Baseline and on a stable dose for ≥ 7 days prior ...

4. Difluprednate (ophthalmic route) - Side effects & dosage - Mayo Clinic

   Difluprednate eye drops is used to treat eye pain, redness, and swelling caused by eye surgery. It is also used to treat an eye condition called endogenous ...

5. Cortisone shots - Doctors & Departments - Mayo Clinic

   Prednisone and other corticosteroids · Rotator cuff injury · Sciatica · Spinal stenosis · Thumb arthritis. Show more related content. Products & Services. A ...

6. Takayasu's arteritis - Diagnosis & treatment - Mayo Clinic

   Medicines · Corticosteroids to control inflammation. The first line of treatment most often is a corticosteroid, such as prednisone (Rayos). · Other medicines ...

7. Orphenadrine (oral route) - Side effects & dosage - Mayo Clinic

   One form of orphenadrine is also used to relieve trembling caused by Parkinson's disease. However, this medicine does not take the place of rest, exercise or ...

8. Lansoprazole, amoxicillin, and clarithromycin (oral route) - Side effects & dosage - Mayo Clinic

   Prednisone; Repaglinide; Rivaroxaban; Tipranavir; Warfarin. Other Interactions. Certain medicines should not be used at or around the time of eating food or ...

9. A Study of Adjuvant Pembrolizumab/Vibostolimab (MK-7684A) Versus Pembrolizumab for Resected High-Risk Melanoma in Participants With High-Risk Stage II-IV Melanoma (MK-7684A-010/KEYVIBE-010) - Mayo Clinic

   (in dosing exceeding 10 mg daily of prednisone equivalent) or any other form of immunosuppressive therapy within 7 days prior the first dose of study ...

10. Daratumumab (intravenous route) - Side effects & uses - Mayo Clinic

    Daratumumab injection is also used together with bortezomib, melphalan, and prednisone to treat patients with newly diagnosed multiple myeloma who cannot ...